Submissions
Login or Register to make a submission.

Author Guidelines

Before submitting, read the journal’s Editorial Policy and Code of Ethics. The OBJN follows the ICMJE Recommendations (Vancouver style).

_______________________________________________________________________________

Mandatory documents

Mandatory

Documents

Downloads

For ALL articles

· Manuscript in the journal's Template (blinded)

· Portuguese: Clique aqui

· English: Click here

· Spanish: Haga clic aquí

· Title Page in the journal's Template

· Portuguese: Clique aqui

· English: Click here

· Spanish: Haga clic aquí

For studies involving human beings or animals

· Research Ethics Committee approval letter.

 

For randomized clinical trials

· CONSORT Flowchart

Download: Click here

· CONSORT Checklist

Download: Click here

For observational and epidemiological studies

· STROBE Checklist

Download: Click here

For all types of quality improvement studies

· SQUIRE 2.0 Checklist

Download: Click here

For qualitative studies

· COREQ Checklist

Download: Click here

For implementation, development, and technological innovation studies

· SQUIRE 2.0 Checklist

Download: Click here

For systematic reviews and meta-analyses

· PRISMA Checklist

Download: Click here

· PRISMA Flowchart

Download: Click here

For scoping reviews

· PRISMA-ScR Checklist

Download: Click here

· PRISMA Flowchart

Download: Click here

_______________________________________________________________________________

Authorship

  • Maximum of six (6) authors. In multicenter studies, more authors may be accepted by the Editor-in-Chief, upon justification in the “Comments for the Editor” field at submission.
  • Adding new authors after submission is not allowed at any stage of the editorial process (including after acceptance or when sending the translated version), in accordance with COPE guidance. Such requests result in the manuscript being archived, and it may be sent again as a new submission.
  • The Title Page must include the full name, e-mail, ORCID, and affiliation of each author, as well as the name and e-mail of the corresponding author.
  • Affiliation: full institution name, in its original language, with up to three levels, followed by city, state, and country. Provide only the affiliation where the research was developed; in cooperation between institutions, both may be cited, with the main one listed first.
  • Each author’s contributions must be declared on the Title Page according to the CRediT taxonomy. To qualify as an author, it is necessary to: (1) have made a substantial contribution to the conception of the study or to data acquisition, analysis, and/or interpretation; (2) have taken part in drafting or critically reviewing the intellectual content; and (3) approve the final version and be accountable for all aspects of the work.
  • Those who only contributed to Funding acquisition, Resources, Supervision, or Project administration are not considered authors and must be listed in the Acknowledgements.

_______________________________________________________________________________

Title Page information

  • Acknowledgements, conflict of interest, funding, preprint, thesis/dissertation, data availability, use of artificial intelligence, and passages suppressed for blind review must be provided on the Title Page, following the template models.
  • Acknowledgements: individuals or institutions that contributed to the study but do not meet the authorship criteria. Do not acknowledge financial support.
  • Funding: full name of the funding institution, in its original language, and the grant number.
  • Conflict of interest: explicitly declare any personal, commercial, academic, or financial relationship that may have influenced the study.
  • Artificial intelligence: in addition to the declaration on the Title Page, describe the tools used and their purpose in the “Comments for the Editor” field, according to the Artificial Intelligence Use Policy.

_______________________________________________________________________________

Preparation and formatting

  • Accepted languages: Portuguese, English, and Spanish, in the sections described in Accepted Manuscript Types.
  • The manuscript must be original, unpublished, and not under review by another journal (except for deposit on a preprint server).
  • Plagiarism and self-plagiarism lead to rejection (Copyright, Plagiarism and Retraction Policy).
  • Manuscript and Title Page in the journal template, in Word (.doc or .docx).
  • A4 page, 2.5 cm margins, Times New Roman 12, justified text, 1.25 cm first-line indent, and 1.5 line spacing. The abstract, descriptors, highlights, tables, speeches, and references are single-spaced.
  • Do not number the pages or use footnotes or endnotes.
  • In manuscripts in Portuguese, English terms must be in italics.
  • Maximum word count (the abstract and references are not counted):

Manuscript type

Maximum word count

Editorial

1500 words

Original Articles

5000 words

Review Articles

5000 words

Implementation, Development, and Technological Innovation

5000 words

Reflection Articles

5000 words

Experience Reports

5000 words

Letter to the Editor

500 words

_______________________________________________________________________________

Manuscript structure

  • Follow the template: title, abstract, descriptors, highlights, introduction, method, results, discussion, conclusion, and references (except for editorials and letters to the editor).
  • It is mandatory to follow the Equator Network guideline corresponding to the method.
  • Clinical trials, systematic reviews, and scoping reviews must report the registration number at the end of the abstract and in the method (see the accepted registries in Accepted Manuscript Types). Reviews must update the search up to the date of submission.

_______________________________________________________________________________

Title

  • In the submission language, up to 15 words, without acronyms or abbreviations, except for international acronyms (e.g., ICNP).
  • Uppercase only at the beginning of the title and in proper nouns.
  • Do not include names of municipalities in the title or objective, except for capitals, macro-regions, or countries.
  • The research design must appear at the end of the title, as a subtitle, preceded by a colon.

_______________________________________________________________________________

Abstract and descriptors

  • Abstract in the submission language, up to 200 words, structured into objective, method, results, and conclusion, without citations and without acronyms or abbreviations, except for international acronyms (e.g., ICNP).
  • Three (3) to six (6) descriptors, in the submission language, extracted from DeCS and/or MeSH.

_______________________________________________________________________________

Highlights

  • Mandatory, except for editorials and letters to the editor. They come right after the descriptors, in the submission language.
  • Two blocks, each with exactly three (3) items: “What is already known” (established knowledge on the topic, which may point out the gap that motivated the study) and “What this article adds” (what the study found and what it means for practice, teaching, or research; do not describe how the study was carried out).
  • Each item is a simple, complete sentence of up to two lines, without citations or abbreviations.
  • Avoid generic sentences such as “The study contributes to nursing”. Good example: “School health education programs that include parents are more effective in promoting healthy lifestyles among children than traditional models.”

_______________________________________________________________________________

Citations and speeches

  • Citations numbered consecutively in order of appearance, in Arabic numerals, superscript and in parentheses, before the final punctuation of the sentence and with no space after the preceding word. E.g., sequential (1-3); interspersed (2-3,5).
  • Do not mention author names in the text, except those that constitute the theoretical or methodological framework. Direct quotations go in quotation marks, without italics.
  • Participant speeches: in a separate paragraph, in italics, without quotation marks, single-spaced, and indented 2 cm from the left margin; the coded identification comes at the end, in parentheses and without italics.

_______________________________________________________________________________

Acronyms

  • Use only internationally standardized acronyms, spelled out the first time they appear. In the title and abstract, only international acronyms are allowed (e.g., ICNP). In tables and figures, use as few as possible, with their meaning in the caption.

_______________________________________________________________________________

Tables and figures

  • A maximum of five (5), inserted in the text right after they are cited, in Times New Roman 12, single spacing, within the margins, always indicating the source.
  • The title must state the city, state abbreviation, country, and year of data collection and, in studies with participants, the number of participants, e.g., (n=15).
  • Tables: charts are also identified as tables. They must be editable in Word, with the title above (without a final period), open on the sides, and without internal lines. Each table must fit on one A4 page in portrait orientation; tables in landscape orientation or longer than one page are not accepted.
  • Figures: graphs, drawings, flowcharts, schemes, diagrams, and photos. Title below the figure (below the source, when there is one), minimum resolution of 900 DPI, editable whenever possible, and a maximum size of 16 x 10 cm. Photos of identifiable people require image use authorization.

_______________________________________________________________________________

References

  • Vancouver style, numbered in order of citation in the text. Type the number manually (e.g., 1. Author AA...), without using Word’s automatic numbering or bullets.
  • At least 80% of the references must be from the last five (5) years, except for historical, review, or exceptionally authorized articles. There is no limit on the number of references.
  • Times New Roman 12, justified, single spacing. Provide the DOI whenever available; otherwise, the access link.
  • Articles published in more than one language must be referenced in English. In review articles, add “[included in the review]” at the end of the references resulting from the review.
  • Abbreviate journal titles according to the NLM Catalog; for national and Latin American journals, use the BVS Portal of Journals or Latindex. If there is no abbreviation, use the full name.
  • Remove the link to reference managers before submitting.

Examples:

1. Bulechek GM, Butcher HK, Dochterman JM. Classificação das Intervenções de Enfermagem – NIC. 6. ed. Rio de Janeiro: Elsevier; 2016.

2. Dordetto P, Pinto G, Rosa T. Pacientes submetidos à cirurgia cardíaca: caracterização sociodemográfica, perfil clínico epidemiológico e complicações. Rev Fac Cienc Med. 2016;18(3):144-9. https://doi.org/10.5327/Z1984-4840201625868

3. Lima DVM. Design of research: a contribution for authors. Online Braz J Nurs [Internet]. 2011 [cited 2022 Sep 11];10(2). Available from: http://www.objnursing.uff.br/index.php/nursing/article/view/3648

4. Magnago C, Pierantoni CR, França T, Garcia AC, Ney MS, Matsumoto K. The influence of family health strategy on health indicators in the municipalities of Rio de Janeiro, Brazil. Online Braz J Nurs. 2011;10(1). https://doi.org/10.5935/1676-4285.20113211 [included in the review]

_______________________________________________________________________________

Peer review, copyright, and preservation

  • The OBJN adopts double anonymous peer review. See the Evaluation Policy and the Editorial Flow.
  • The authors retain the copyright of the work without restrictions and grant the OBJN the right of first publication (manuscripts published as of 10/24/2026). Articles are published under the CC BY 4.0 license.
  • Retractions follow the COPE guidelines (Copyright, Plagiarism and Retraction Policy).
  • The OBJN encourages authors to deposit the published version in institutional repositories. Authorizations can be consulted in Diadorim or Miguilim.

_______________________________________________________________________________

*Updated on 10/23/2026.

Submission Preparation Checklist

As part of the submission process, authors are required to check off their submission’s compliance with all of the following items. Submissions that do not adhere to these guidelines will be returned to the authors.

  • The manuscript follows the Guidelines for Authors and uses the journal Template, in a blinded version (without identification of the authors or their institutions).
  • The Title Page, completed in the template, was attached with the information of all authors.
  • The checklist and/or flow diagram of the Equator Network guideline corresponding to the method and, for research involving human beings or animals, the Research Ethics Committee approval were attached.
  • The manuscript presents the highlights, with three items in each block (except for editorials and letters to the editor).
  • In clinical trials, systematic reviews, and scoping reviews, the registration number appears at the end of the abstract and in the method.
  • The manuscript is original, unpublished, and not under review by another journal (except for a preprint reported on the Title Page).
  • Conflicts of interest, funding, data availability, and use of artificial intelligence were declared on the Title Page.
  • All authors meet the authorship criteria, had their contributions declared according to the CRediT taxonomy, and approved the submitted version.
  • The manuscript has up to six authors or, in multicenter studies, the justification was provided in the “Comments for the Editor” field. The list of authors is final: adding authors after submission is not allowed.
  • The authors retain the copyright, grant the OBJN the right of first publication, and are aware that the article will be published under the CC BY 4.0 license.

Original Articles

These are quantitative (clinical or non-clinical), qualitative, or mixed-methods studies. All study modalities will equally have space for publication in OBJN. All original research manuscripts must include an introduction with a clear and concise description of the knowledge gap and a clear and concise objective, as well as: theoretical framework or philosophical orientation, typology (design, method, or study design), participants, data collection and analysis processes and procedures, ethical considerations, legitimacy and credibility issues and approaches, findings, and implications of those findings. Clinical trials must be registered on recognized platforms, national (like ReBEC) or international (like ClinicalTrials.gov) platforms before data collection begins.

Implementation, Development, and Technological Innovation

These are long articles presenting the description of implementation studies, research applied to professional practice, and/or technological innovation development. They must follow the SQUIRE guide and mandatorily contain: background (state of the art or technique), problem (current diagnosis), proposed solution to the problem, technology differential, benefits, technology results, and market potential. This type of article is considered original.

Letter to the Editor

Involves the submission of comments, questions, and/or critiques regarding published articles. Maximum of one page.

Privacy Statement

The names and email addresses entered in this journal site will be used exclusively for the stated purposes of this journal and will not be made available for any other purpose or to any other party.